HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Vermont P Dia Selected Research

Pancreatin

1/2014Pepsin-pancreatin protein hydrolysates from extruded amaranth inhibit markers of atherosclerosis in LPS-induced THP-1 macrophages-like human cells by reducing expression of proteins in LOX-1 signaling pathway.
1/2014Peptides in pepsin-pancreatin hydrolysates from commercially available soy products that inhibit lipopolysaccharide-induced inflammation in macrophages.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Vermont P Dia Research Topics

Disease

11Inflammation (Inflammations)
12/2021 - 08/2009
9Neoplasms (Cancer)
01/2022 - 12/2009
6Colonic Neoplasms (Colon Cancer)
01/2019 - 09/2010
3Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 08/2014
2Neoplasm Metastasis (Metastasis)
12/2011 - 09/2010
1Colitis
06/2019
1Body Weight (Weight, Body)
06/2019
1Leukemia
01/2018
1Ovarian Neoplasms (Ovarian Cancer)
02/2017
1Carcinogenesis
01/2016
1Pancreatic Neoplasms (Pancreatic Cancer)
01/2015
1Atherosclerosis
01/2014
1Necrosis
01/2014
1Leukemia L1210
03/2010

Drug/Important Bio-Agent (IBA)

10Peptides (Polypeptides)IBA
03/2018 - 12/2009
5LipopolysaccharidesIBA
06/2019 - 08/2011
5Proteins (Proteins, Gene)FDA Link
01/2018 - 09/2010
3Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2019 - 04/2011
3Protein HydrolysatesFDA Link
01/2014 - 08/2009
2ApigeninIBA
01/2022 - 12/2021
2LuteolinIBA
02/2017 - 01/2015
2Caspase 3 (Caspase-3)IBA
01/2015 - 03/2010
2Pepsin A (Pepsin)IBA
01/2014 - 01/2014
2Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2014 - 08/2011
2PancreatinIBA
01/2014 - 01/2014
2AntioxidantsIBA
10/2012 - 08/2011
2Subtilisins (Subtilopeptidase A)IBA
10/2012 - 08/2011
2IntegrinsIBA
12/2011 - 04/2011
2aspartic acid glycine arginineIBA
04/2011 - 03/2010
1Whey ProteinsIBA
01/2022
1PhytochemicalsIBA
01/2022
1CurcuminIBA
12/2021
1TanninsIBA
12/2020
1Dimethyl Sulfoxide (DMSO)FDA LinkGeneric
12/2020
1CytokinesIBA
06/2019
1sodium sulfate (sodium bisulfate)FDA LinkGeneric
06/2019
1Dextrans (Dextran)FDA Link
06/2019
1Peroxidase (Myeloperoxidase)IBA
06/2019
1Pattern Recognition ReceptorsIBA
01/2018
1phorbol-12-myristateIBA
01/2018
1Reactive Oxygen Species (Oxygen Radicals)IBA
01/2018
1Toll-Like Receptor 4IBA
01/2018
1InflammasomesIBA
12/2017
1Paclitaxel (Taxol)FDA LinkGeneric
02/2017
1TrypsinIBA
01/2016
1GemcitabineFDA Link
01/2015
1Cytochromes c (Cytochrome c)IBA
01/2015
1Class E Scavenger Receptors (Lectin Like Oxidized Low Density Lipoprotein Receptor 1)IBA
01/2014
1Matrix Metalloproteinase 9 (Gelatinase B)IBA
01/2014
1SaponinsIBA
07/2013
1TeaIBA
07/2013
1AzoxymethaneIBA
07/2013
1AcidsIBA
05/2013
1Focal Adhesion Protein-Tyrosine KinasesIBA
12/2011
1Proliferating Cell Nuclear Antigen (PCNA)IBA
12/2011
1Dinoprostone (PGE2)FDA Link
08/2011
1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
08/2011
1Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
08/2011
1Plant LectinsIBA
09/2010
1Biological ProductsIBA
09/2010
1LactoferrinIBA
09/2010
1ClusterinIBA
09/2010
1lactoferricin BIBA
09/2010
1Protease Inhibitors (Protease Inhibitor)IBA
09/2010
1NF-kappa B (NF-kB)IBA
12/2009
1Glycine max beta-conglycinin proteinIBA
08/2009
1LipidsIBA
08/2009

Therapy/Procedure

1Therapeutics
01/2019